Amgen's head of R&D, Davide Reese, said the results "validate our approach to move Lumakras earlier within the treatment paradigm through novel therapeutic combinations." The ORR was similar (62% ...

HAIKOU, August 24. /TASS/. An innovative American drug Lumakras (also known as Sotorasib) for lung cancer and other types of cancer may soon become available at Hainan Lecheng Medical Cluster ...

Lumakras was approved in May by the FDA as a second-line treatment for KRAS G12c-mutated non-small cell lung cancer (NSCLC), becoming the first drug against a target that was long considered ...